Ciprofloxacin induction of a susceptibility determinant in Pseudomonas aeruginosa.
about
Ribosomally encoded antibacterial proteins and peptides from PseudomonasExplosive cell lysis as a mechanism for the biogenesis of bacterial membrane vesicles and biofilmsResponses of Pseudomonas aeruginosa to antimicrobialsNewly introduced genomic prophage islands are critical determinants of in vivo competitiveness in the Liverpool Epidemic Strain of Pseudomonas aeruginosaRole of lon, an ATP-dependent protease homolog, in resistance of Pseudomonas aeruginosa to ciprofloxacinThe regulatory repertoire of Pseudomonas aeruginosa AmpC ß-lactamase regulator AmpR includes virulence genesRole of Pseudomonas aeruginosa dinB-encoded DNA polymerase IV in mutagenesis.Defining the Pseudomonas aeruginosa SOS response and its role in the global response to the antibiotic ciprofloxacinRapid clinical bacteriology and its future impactComplex ciprofloxacin resistome revealed by screening a Pseudomonas aeruginosa mutant library for altered susceptibility.The development of ciprofloxacin resistance in Pseudomonas aeruginosa involves multiple response stages and multiple proteins.Comparative genome and transcriptome analysis reveals distinctive surface characteristics and unique physiological potentials of Pseudomonas aeruginosa ATCC 27853Biological cost of pyocin production during the SOS response in Pseudomonas aeruginosa.Fitness landscape of antibiotic tolerance in Pseudomonas aeruginosa biofilmsReverting antibiotic tolerance of Pseudomonas aeruginosa PAO1 persister cells by (Z)-4-bromo-5-(bromomethylene)-3-methylfuran-2(5H)-one.The accessory genome of Pseudomonas aeruginosaC-di-GMP regulates Pseudomonas aeruginosa stress response to tellurite during both planktonic and biofilm modes of growthEffect of antibiotic treatment on bacteriophage production by a cystic fibrosis epidemic strain of Pseudomonas aeruginosa.The fatty acid signaling molecule cis-2-decenoic acid increases metabolic activity and reverts persister cells to an antimicrobial-susceptible state.Role of bacteriocins in mediating interactions of bacterial isolates taken from cystic fibrosis patientsBreaking the rules: bacteria that use several DNA polymerase IIIs.Human host defense peptide LL-37 stimulates virulence factor production and adaptive resistance in Pseudomonas aeruginosa.Antibiotics as intermicrobial signaling agents instead of weapons.Contribution of stress responses to antibiotic tolerance in Pseudomonas aeruginosa biofilmsRNA signatures allow rapid identification of pathogens and antibiotic susceptibilitiesIntrinsic Antimicrobial Resistance Determinants in the Superbug Pseudomonas aeruginosa.Human Granulocyte Macrophage Colony-Stimulating Factor Enhances Antibiotic Susceptibility of Pseudomonas aeruginosa Persister Cells.A Rapid Molecular Test for Determining Yersinia pestis Susceptibility to Ciprofloxacin by the Quantification of Differentially Expressed Marker Genes.Genomic analysis of an emerging multiresistant Staphylococcus aureus strain rapidly spreading in cystic fibrosis patients revealed the presence of an antibiotic inducible bacteriophage.Cellular reporter screens for inhibitors of Burkholderia pseudomallei targets in Pseudomonas aeruginosaComparative genome analysis of ciprofloxacin-resistant Pseudomonas aeruginosa reveals genes within newly identified high variability regions associated with drug resistance development.PrtR homeostasis contributes to Pseudomonas aeruginosa pathogenesis and resistance against ciprofloxacin.Novel therapeutic strategies to counter Pseudomonas aeruginosa infections.PBP3 inhibition elicits adaptive responses in Pseudomonas aeruginosa.Transcriptomics as a tool to discover new antibacterial targets.Tolerance and pharmacokinetics of a ciprofloxacin-coated sinus stent in a preclinical model.Involvement of Fe uptake systems and AmpC β-lactamase in susceptibility to the siderophore monosulfactam BAL30072 in Pseudomonas aeruginosa.Biophysicochemical characterization of Pyocin SA189 produced by Pseudomonas aeruginosa SA189.Interaction of Staphylococcus aureus persister cells with the host when in a persister state and following awakening.Quinolones sensitize gram-negative bacteria to antimicrobial peptides.
P2860
Q26992214-531B89A2-EAFE-4AB3-9595-25678FBB5C05Q27320770-791FBE70-D93A-4A41-AA9E-453CD2F6B15FQ28305587-55A802A0-A544-47EA-A00E-470D05FFD613Q28492507-53A983C1-B8A0-41FC-9652-4A77DE42A1F5Q28492686-274BFBA9-FA8B-4F9B-B9CF-D2EA3D0DC30AQ28493156-87826D3A-2FDF-4A0E-8B24-722DF8959067Q29346764-A612233D-44C0-4AD1-AFD5-11DA1F947F9FQ29346807-12C83E99-B05F-430E-BD62-4070DE318137Q30459288-1B966399-DA51-4B7D-8389-E57F1BEE4FABQ33372694-0D772EF1-F725-46E0-BC64-0F75299BB962Q33653162-666B2995-C5AB-40A4-8B2C-0EEAA9D77C12Q33786619-6BC21555-2639-487A-ADFD-7D6BEFAD070FQ34056908-861DA930-B138-48EF-AC7C-B9ABC1696B60Q34058108-3A6EDA24-FB11-4AEC-91FA-81D3013DC046Q34430056-7E7772D7-49D9-4390-BA4A-46E92CF8F591Q34431840-31B1942A-1A87-4B23-AA1B-0903FCC0C6F4Q34477110-7FA291CF-0632-4C45-A05E-1F8FF4CAE75FQ34483463-F41599EC-7C92-4E54-9704-E3C5D5DCD2B7Q34594203-A2C7C3C1-9098-4586-9205-26A95E962FFCQ34746975-CC7347D3-263A-462C-9DB3-C679F92A7549Q34953383-C8D90A39-C7D3-491B-A91B-6E8DCDAC42D2Q35070095-119D42AA-4909-44CB-8666-754BD19694C5Q35194014-57C16E1E-0A38-4C0A-A2A6-895E29254BE3Q35746192-7156C61D-E42C-4092-A3BE-5D7C8AC0EE63Q35924808-3291B91B-C914-4C0B-BC2E-F7FD5229D727Q36227302-267459DC-901A-440A-BB04-05774C8BB8CAQ36329466-CD0B2E69-00CF-4AFA-AFD8-C199CBF127D5Q36913976-3FF90271-A70D-4877-9AA5-E16E9A6A7BCDQ37069059-C61DB0BA-0938-4408-928C-AD4B53132452Q37258639-C212CADE-FFA0-44E4-8DD2-D735E713FDDAQ37469236-AB84A8A2-0564-434D-BF6A-11C2C065BA8EQ37713295-FCB8DC38-E521-4C2C-8867-6746C4440314Q37984505-6188BF56-ED6F-49FA-970C-933677572D4BQ38309969-3D1AD683-346B-4162-A2CA-1661D099AAEBQ38910040-8CC451C6-F84B-4A1E-8342-674F654C5F9AQ39089235-65C84709-063E-45F6-9E5C-C417519C5404Q40003707-57FF962A-8535-46DC-AD7B-A9B3C80FF646Q40184275-8936F523-6789-482F-BBBF-656319141EDEQ40582476-EA612FBE-BC61-4ED1-BF5C-F2D1B30EEC9EQ41473930-82175748-E5A8-4B4F-B6AF-CA36EB4B80C0
P2860
Ciprofloxacin induction of a susceptibility determinant in Pseudomonas aeruginosa.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Ciprofloxacin induction of a susceptibility determinant in Pseudomonas aeruginosa.
@en
type
label
Ciprofloxacin induction of a susceptibility determinant in Pseudomonas aeruginosa.
@en
prefLabel
Ciprofloxacin induction of a susceptibility determinant in Pseudomonas aeruginosa.
@en
P2860
P1476
Ciprofloxacin induction of a susceptibility determinant in Pseudomonas aeruginosa.
@en
P2860
P304
P356
10.1128/AAC.49.8.3222-3227.2005
P407
P577
2005-08-01T00:00:00Z